Newsfeeds - Spark Newswire

1 minute read

Costco’s Price Target Cut By This Analyst? Plus Citigroup Sees $91 For Wynn Resorts

September 26, 10:13 AM

Raymond James cut the price target on Costco Wholesale Corporation (NASDAQ: COST) from $600 to $560. Raymond James analyst Bobby Griffin maintained an Outperform rating on the stock. Costco shares rose 2.3% to $476.97 on Monday.

ADTN

1 minute read

Las Vegas Sands To Surge 70%? Here Are 5 Other Price Target Changes For Monday

By Lisa Levin

September 26, 7:53 AM

Citigroup raised Las Vegas Sands Corp. (NYSE: LVS) price target from $58 to $60. Citigroup analyst George Choi maintained the stock with a Buy. Las Vegas Sands shares rose 0.5% to close at $35.47 on Friday.

ADTN

1 minute read

Analyst Ratings

Expert Ratings for Adtran

By Benzinga Insights

September 8, 3:29 PM

Analysts have provided the following ratings for Adtran (NASDAQ:ADTN) within the last quarter:

ADTN

6 minute read

Why Allena Pharmaceuticals Tumbled Over 30%; Here Are 85 Biggest Movers From Yesterday

By Lisa Levin

September 7, 5:16 AM

Gainers Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) shares jumped 91.3% to close at $28.50 on Tuesday amid post-IPO volatility.

ADT

4 minute read

Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday’s Mid-Day Session

By Lisa Levin

September 6, 1:36 PM

Gainers HyreCar Inc. (NASDAQ: HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.

ADT

2 minute read

Bed Bath & Beyond, Eiger BioPharmaceuticals And Some Other Big Stocks Moving Lower On Tuesday

By Lisa Levin

September 6, 11:08 AM

ADTN

15 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For July 14, 2022

By Benzinga Insights

July 14, 10:06 AM

Upgrades

AAT

1 minute read

Needham Initiates Coverage On Adtran with Buy Rating, Announces Price Target of $28

By Benzinga Newsdesk

July 14, 6:14 AM

Needham analyst Ryan Koontz initiates coverage on Adtran (NASDAQ:ADTN) with a Buy rating and announces Price Target of $28.

ADTN

1 minute read

ADTRAN Announces FDI Approvals Completed For ADTRAN/ADVA Business Combination

By Bill Haddad

July 6, 6:55 AM

ADTRAN, Inc. (NASDAQ:ADTN) today announced that it has received foreign direct investment (FDI) approval from the German Ministry for Economic Affairs and Climate Action (Bundesministerium für Wirtschaft und

ADTN

27 minute read

Earnings Scheduled For May 4, 2022

By Benzinga Insights

May 4, 4:36 AM

Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.

ABC